Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuraxis (NRXS) Notes Payables (2022 - 2025)

Neuraxis (NRXS) has disclosed Notes Payables for 4 consecutive years, with $148293.0 as the latest value for Q4 2025.

  • Quarterly Notes Payables fell 3.8% to $148293.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $148293.0 through Dec 2025, down 3.8% year-over-year, with the annual reading at $148293.0 for FY2025, 3.8% down from the prior year.
  • Notes Payables hit $148293.0 in Q4 2025 for Neuraxis, down from $195658.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $4.7 million in Q2 2024 to a low of $84307.0 in Q1 2025.
  • Historically, Notes Payables has averaged $870608.2 across 4 years, with a median of $194249.0 in 2023.
  • Biggest five-year swings in Notes Payables: surged 288.39% in 2024 and later plummeted 97.43% in 2025.
  • Year by year, Notes Payables stood at $228342.0 in 2022, then crashed by 35.16% to $148062.0 in 2023, then grew by 4.11% to $154152.0 in 2024, then fell by 3.8% to $148293.0 in 2025.
  • Business Quant data shows Notes Payables for NRXS at $148293.0 in Q4 2025, $195658.0 in Q3 2025, and $121433.0 in Q2 2025.